ONCOTECT | Cancer Screening

Oncotect The world's first non-invasive at-home cancer screening test for dogs. It is a Raleigh-based biotech startup committed to pioneering early screening of cancer risks in dogs using their urine. The company’s patent-pending in-vitro scientific test relies on its proprietary technology to detect cancerous metabolites. Oncotect is the only urine-based non-invasive, convenient, affordable, and accessible multi-cancer screening test available for dogs.

A highly accurate, non-invasive, early cancer screening tool, backed by scientific clinical research.

*50+ Vets used and recommended
*83% Sensitivity, 96% Specificity